Jenny Link is a Dermatology physician affiliated with Mayo Clinic. OpenAlex indexes 41 publications with 5,598 citations (h-index 19). By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
30.8%Corticosteroid30.8%Hydrocortisone46%Clobetasol Propionate43%Betamethasone Diprop Augmented10%Part D<11 patientsAnti-infectives
28.1%Azole Antifungal13.4%Ketoconazole100%Part D≥40 patientsTetracycline-class Drug7.9%Doxycycline Hyclate51%Doxycycline Monohydrate49%Part D<11 patients+ 2 more classes in this area
Dermatology
19.3%Corticosteroid16.8%Triamcinolone Acetonide100%Part D≥54 patientsInterleukin-4 Receptor alpha Antagonist2.5%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 76534 Longitudinal 3D Total Body Photography Improves Detection of Earlier Stage and Thinner Melanomas: Novel Insights from a Tertiary-Center, Retrospective Analysis
Journal of the American Academy of Dermatology
2026 - Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
Multiple Sclerosis and Related Disorders
2022
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”